Thursday, December 15, 2011

Covidien Announces Conference Call and Webcast


DUBLIN - Thursday, December 15th 2011 [ME NewsWire]

(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it will hold a conference call and webcast for investors on Thursday, December 15, 2011, at 8:00AM ET.

This call can be accessed three ways:

At Covidien’s website: http://investor.covidien.com
By telephone: For both “listen-only” participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 800-510-9661. For participants outside the U.S., the dial-in number is 617-614-3452. The access code for all callers is 29488682.
Through an audio replay: A replay of the conference call will be available beginning at 11:00 a.m. on December 15, 2011, and ending at 5:00 p.m. on December 22, 2011. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 65354792.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit http://www.covidien.comto learn more about our business.

Contacts

Covidien

Eric Kraus, 508-261-8305

Senior Vice President

Corporate Communications

eric.kraus@covidien.com


Coleman Lannum, CFA, 508-452-4343

Vice President

Investor Relations

cole.lannum@covidien.com


Bruce Farmer, 508-452-4372

Vice President

Public Relations

bruce.farmer@covidien.com


Todd Carpenter, 508-452-4363

Director

Investor Relations

todd.carpenter@covidien.com

No comments:

Post a Comment